SYRE
HealthcareSpyre Therapeutics, Inc.
Prev Close
$40.41
Open
$40.92
High
$42.40
Low
$40.21
Volume
369.6K
Market Cap
$2.50B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Spyre Therapeutics, Inc. (SYRE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $5.16M. The most recent insider transaction was by Burrows Scott L (officer: Chief Financial Officer), who sold $203.2K worth of shares on Mar 3, 2026. Spyre Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.50B.
SYRE Insider Trading Activity
SYRE Insider Buying Activity
The following table shows recent insider purchases of Spyre Therapeutics, Inc. (SYRE) stock reported via SEC Form 4 filings.
No insider buying activity found for SYRE in the last 12 months.
SYRE Insider Selling Activity
The following table shows recent insider sales of Spyre Therapeutics, Inc. (SYRE) stock reported via SEC Form 4 filings.